NCT02478580View on ClinicalTrials.gov

Armodafinil (Nuvigil), Postoperative Recovery of OSA (Obstructive Sleep Apnea) and Obese Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

September 30, 2013

Study Completion Date

January 31, 2016

Conditions
ObesityPremature Recovery From Anesthesia
Interventions
DRUG

Nuvigil

Patients will receive Nuvigil before the surgery

DRUG

Placebo

Placebo will be given before surgery

Trial Locations (1)

75390-9068

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT02478580 - Armodafinil (Nuvigil), Postoperative Recovery of OSA (Obstructive Sleep Apnea) and Obese Patients | Biotech Hunter | Biotech Hunter